Day One Biopharmaceuticals Inc - DAWN - stock price prediction, stock price target, analyst ratings from 8 analysts

Day One Biopharmaceuticals Inc has a share price target of US$ 28, revenue growth forecast of 15.7%, and profit growth estimate of -51.2% for FY25, based on top 8 analyst calls.